Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of XOMA patents

Patents where

Current Assignee

Name

XOMA

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11534428 Compositions and methods for delaying the incidence of labor	Patent 11534428 was granted and assigned to XOMA on December, 2022 by the United States Patent and Trademark Office.	ObsEva	XOMA	United States Patent and Trademark Office	11534428	December 27, 2022
‌ US Patent 7829093 Method of treating an IL-1 related autoimmune disease or condition	Patent 7829093 was granted and assigned to XOMA on November, 2010 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7829093	November 9, 2010
‌ US Patent 7829094 Method of treating an IL-1 related cancer	Patent 7829094 was granted and assigned to XOMA on November, 2010 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7829094	November 9, 2010
‌ US Patent 7695717 Method of treating an IL-1 related inflammatory disease or condition	Patent 7695717 was granted and assigned to XOMA on April, 2010 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7695717	April 13, 2010
‌ US Patent 7192737 Methods and materials for increasing expression of recombinant polypeptides	Patent 7192737 was granted and assigned to XOMA on March, 2007 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7192737	March 20, 2007
‌ US Patent 7582742 Method of treating or preventing an IL-1 related disease or condition	Patent 7582742 was granted and assigned to XOMA on September, 2009 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7582742	September 1, 2009
‌ US Patent 7988968 Method of treating an IL-1 related coronary condition	Patent 7988968 was granted and assigned to XOMA on August, 2011 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7988968	August 2, 2011
‌ US Patent 8377442 Method of treating inflammatory eye disease with IL-1β binding antibodies	Patent 8377442 was granted and assigned to XOMA on February, 2013 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	8377442	February 19, 2013
‌ US Patent 9714285 TGF-beta-specific antibodies and methods of use thereof for treatment	Patent 9714285 was granted and assigned to XOMA on July, 2017 by the United States Patent and Trademark Office.	XOMA	XOMA	United States Patent and Trademark Office	9714285	July 25, 2017
‌ US Patent 7744866 IL-1β binding antibodies and binding fragments thereof	Patent 7744866 was granted and assigned to XOMA on June, 2010 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7744866	June 29, 2010
‌ US Patent 7744865 IL1-β Binding antibodies and fragments thereof	Patent 7744865 was granted and assigned to XOMA on June, 2010 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7744865	June 29, 2010
‌ US Patent 9206252 Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereof	Patent 9206252 was granted and assigned to XOMA on December, 2015 by the United States Patent and Trademark Office.	XOMA	XOMA	United States Patent and Trademark Office	9206252	December 8, 2015
‌ US Patent 7943121 IL-1β binding antibodies and fragments thereof	Patent 7943121 was granted and assigned to XOMA on May, 2011 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7943121	May 17, 2011
‌ US Patent 9145458 Antibodies specific for TGF-β and methods of treatment thereof	Patent 9145458 was granted and assigned to XOMA on September, 2015 by the United States Patent and Trademark Office.	XOMA	XOMA	United States Patent and Trademark Office	9145458	September 29, 2015
‌ US Patent 10294658 Flexible manufacturing system	Patent 10294658 was granted and assigned to XOMA on May, 2019 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	10294658	May 21, 2019
‌ US Patent 9139646 Methods for the treatment of uveitis with IL-1β binding antibodies	Patent 9139646 was granted and assigned to XOMA on September, 2015 by the United States Patent and Trademark Office.	XOMA	XOMA	United States Patent and Trademark Office	9139646	September 22, 2015
‌ US Patent 7396661 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries	Patent 7396661 was granted and assigned to XOMA on July, 2008 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7396661	July 8, 2008
‌ US Patent 7291451 Modulation of pericyte proliferation	Patent 7291451 was granted and assigned to XOMA on November, 2007 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7291451	November 6, 2007
‌ US Patent 8926976 Modulators	Patent 8926976 was granted and assigned to XOMA on January, 2015 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	8926976	January 6, 2015
‌ US Patent 7247454 Methods for recombinant peptide production	Patent 7247454 was granted and assigned to XOMA on July, 2007 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7247454	July 24, 2007
‌ US Patent 8821879 Anti-botulism antibody coformulations	Patent 8821879 was granted and assigned to XOMA on September, 2014 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	8821879	September 2, 2014
‌ US Patent 7794976 Methods and materials for expression of a recombinant protein	Patent 7794976 was granted and assigned to XOMA on September, 2010 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7794976	September 14, 2010
‌ US Patent 9725510 Modulators	Patent 9725510 was granted and assigned to XOMA on August, 2017 by the United States Patent and Trademark Office.	XOMA	XOMA	United States Patent and Trademark Office	9725510	August 8, 2017
‌ US Patent 7695718 Methods for the treatment of IL-1β related diseases	Patent 7695718 was granted and assigned to XOMA on April, 2010 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	7695718	April 13, 2010
‌ US Patent 9732143 Methods and materials for enhancing functional protein expression in bacteria	Patent 9732143 was granted and assigned to XOMA on August, 2017 by the United States Patent and Trademark Office.		XOMA	United States Patent and Trademark Office	9732143	August 15, 2017

Results per page:

53 results

0 selected

53 results

0 selected